92 Background: Capecitabine-based neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer (LARC)
In low-risk patients, upfront surgery may be an appropriate option
After neoadjuvant CRT for rectal cancer, a large number of previously unresectable tumours can be Review and analysis of the data
If cancer is still found in the tissue removed by surgery after neoadjuvant chemo has been given, your doctor may recommend: an oral chemo drug called capecitabine (Xeloda) for 18 to 24 weeks
Omission of preoperative RT is conditionally recommended in selected patients with lower risk of QUICK TAKE Neoadjuvant Cemiplimab for Squamous-Cell Carcinoma 02:16
To determine the clinical and pathological outcome of locally advanced rectal cancer patients treated with neoadjuvant chemoradiation (chemoradiotherapy [CRT]) followed by curative surgery and to identify predictive factors of pathological complete response (pCR)